MindBio Therapeutics Adds AI Fatigue Detection to Voice Diagnostics Platform

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the development of AI-powered fatigue recognition technology that analyzes voice patterns, intended as a commercial feature for its Edge AI Intoxication Detection Kiosks. The addition targets high-risk industries such as aviation, road transport, and mining, complementing the company’s broader voice-based diagnostics platform designed to identify intoxication and neurological impairment.

The fatigue detection module leverages MindBio’s existing AI prediction model, which uses over 50 million data points to detect alcohol intoxication with high accuracy through voice analysis. The company plans to integrate this new capability into its enterprise platform, which includes Edge-AI kiosks with bespoke hardware and software. Initial commercial testing of the kiosk platform is expected in late second quarter 2026.

This expansion underscores MindBio’s commitment to enhancing workplace safety in environments where impairment and fatigue pose significant risks. The technology could help prevent accidents in sectors like mining, where operator alertness is critical, and aviation, where pilot fatigue is a known safety concern. By adding fatigue detection, MindBio aims to offer a more comprehensive solution for monitoring cognitive states in real time.

MindBio Therapeutics is a biotechnology company commercializing AI prediction technologies for drug and alcohol intoxication detection via voice analysis. The company’s platform is designed for enterprise environments including mining, aviation, construction, and law enforcement. The latest news and updates relating to MBQIF are available in the company’s newsroom at https://nnw.fm/MBQIF.

The development of fatigue detection technology comes as industries increasingly seek non-invasive methods to monitor employee well-being and performance. Voice analysis offers a passive, scalable solution that can be deployed at checkpoints or integrated into routine operations. MindBio’s approach could set a new standard for safety protocols, potentially reducing incidents caused by fatigue-related errors.

For the full press release, visit https://nnw.fm/WWgcb. Note to investors: The latest news and updates relating to MBQIF are available in the company’s newsroom at the above link.

This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is MindBio Therapeutics Adds AI Fatigue Detection to Voice Diagnostics Platform.

The post MindBio Therapeutics Adds AI Fatigue Detection to Voice Diagnostics Platform appeared first on citybuzz.